X4 Pharmaceuticals (XFOR) Other Working Capital Changes (2017 - 2025)
X4 Pharmaceuticals' (XFOR) quarterly Other Working Capital Changes came in at -$3.4 million in Q4 2025, down 758.75% YoY from $514000.0 in Q4 2024, and down 704.28% on a QoQ basis from -$421000.0 in Q3 2025.
X4 Pharmaceuticals (XFOR) Other Working Capital Changes (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals (XFOR) has 1 years of Other Working Capital Changes data on file, last reported at -$296000.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 758.75% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.2 million (down 521.96% YoY) and the FY2025 annual result came in at -$4.2 million, down 521.96% from the prior year.
- Other Working Capital Changes retreated to -$3.4 million in Q4 2025, from -$421000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.8 million in Q4 2023 to a low of -$3.4 million in Q4 2025.
- A 5-year average of -$59800.0 and a median of $110500.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 905.0% — and 2025, when it sank 758.75%.
- Tracing XFOR's Other Working Capital Changes over 5 years: stood at $1.7 million in 2021, then sank by 55.89% to $768000.0 in 2022, then soared by 138.15% to $1.8 million in 2023, then plunged by 71.9% to $514000.0 in 2024, then slumped by 758.75% to -$3.4 million in 2025.
- The last three Other Working Capital Changes figures came in at -$296000.0 (Q4 2025), -$200000.0 (Q3 2025), and -$229000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.39 Mn |
| Dec 31, 2025 | -3.39 Mn |
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | -421,000.00 |
| Sep 30, 2025 | -421,000.00 |
| Sep 30, 2025 | -421,000.00 |
| Jun 30, 2025 | -240,000.00 |
| Jun 30, 2025 | -240,000.00 |
| Jun 30, 2025 | -240,000.00 |
| Mar 31, 2025 | -201,000.00 |
| Mar 31, 2025 | -201,000.00 |
| Mar 31, 2025 | -201,000.00 |
| Dec 31, 2024 | 514,000.00 |
| Dec 31, 2024 | 514,000.00 |
| Dec 31, 2024 | 514,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Jun 30, 2024 | -336,000.00 |
| Jun 30, 2024 | -336,000.00 |